Cue Biopharma (CUE) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to -$18.7 million.
- Cue Biopharma's Enterprise Value rose 4231.65% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.7 million, marking a year-over-year increase of 4231.65%. This contributed to the annual value of -$23.4 million for FY2024, which is 5207.48% up from last year.
- Per Cue Biopharma's latest filing, its Enterprise Value stood at -$18.7 million for Q3 2025, which was up 4231.65% from -$28.0 million recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Enterprise Value ranged from a high of -$14.0 million in Q1 2025 and a low of -$76.3 million during Q4 2022
- Its 5-year average for Enterprise Value is -$50.7 million, with a median of -$57.9 million in 2023.
- Per our database at Business Quant, Cue Biopharma's Enterprise Value crashed by 5033.24% in 2021 and then soared by 6576.08% in 2025.
- Quarter analysis of 5 years shows Cue Biopharma's Enterprise Value stood at -$64.4 million in 2021, then fell by 18.51% to -$76.3 million in 2022, then surged by 36.03% to -$48.8 million in 2023, then soared by 52.07% to -$23.4 million in 2024, then increased by 20.04% to -$18.7 million in 2025.
- Its Enterprise Value stands at -$18.7 million for Q3 2025, versus -$28.0 million for Q2 2025 and -$14.0 million for Q1 2025.